You have 9 free searches left this month | for more free features.

cemiplimab-rwlc

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

Terminated
  • Cutaneous Squamous Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • Cemiplimab-Rwlc
  • Tucson, Arizona
  • +1 more
Jul 26, 2022

Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Cemiplimab-Rwlc
  • (no location specified)
Aug 1, 2022

Glioblastoma Trial in United States (Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc)

Completed
  • Glioblastoma
  • Ad-RTS-hIL-12
  • +2 more
  • Los Angeles, California
  • +6 more
Nov 3, 2021

Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cancer Trial in United States (CMP-001, cemiplimab-rwlc)

Recruiting
  • Merkel Cell Carcinoma
  • +4 more
  • Jacksonville, Florida
  • +6 more
Feb 24, 2022